MY103817A - Chloroaniline derivatives - Google Patents
Chloroaniline derivativesInfo
- Publication number
- MY103817A MY103817A MYPI89000167A MYPI19890167A MY103817A MY 103817 A MY103817 A MY 103817A MY PI89000167 A MYPI89000167 A MY PI89000167A MY PI19890167 A MYPI19890167 A MY PI19890167A MY 103817 A MY103817 A MY 103817A
- Authority
- MY
- Malaysia
- Prior art keywords
- group
- alkyl
- atom
- alkylene
- substituted
- Prior art date
Links
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical class ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 title 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical group [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- -1 TRIFLUOROMETHYL GROUP Chemical group 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 101100134927 Gallus gallus COR8 gene Proteins 0.000 abstract 1
- 206010062109 Reversible airways obstruction Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 150000001721 carbon Chemical class 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
THE INVENTION PROVIDES COMPOUNDS OF THE GENERAL FORMULA (1) (FORMULA 1) AND PHYSIOLOGICALLY ACCEPTABLE SALTS AND SOLVATES THEREOF, WHEREIN Q REPRESENTS CHLORINE ATOM OR A TRIFLUOROMETHYL GROUP; X REPRESENTS BOND OR A C2- 6 ALKYLENE, C2- 6 ALKENYLENE OR C2- 6 ALKYNYLENE CHAIN AND Y REPRESENTS A BOND, OR A C1- 6 ALKYLENE, C2- 6 ALKENYLENE OR C2- 6 ALKYNYLENE CHAIN WITH THE PROVISO THAT THE SUM TOTAL OR CORBON ATOMS IN THE CHAINS X AND Y IS NOT MORE THAN 10, AND THE CHAINS XCH2 AND CH2Y MAY EACH BE OPTIONALLY SUBSTITUTED BY ONE OR TWO C1- 3 ALKYL GROUPS, OR, WHEN ONE CARBON ATOM IS SUBSTITUTEDBY TWO ALKYL GROUPS, THESE MAY BE LINKED TO FORM AN ALKYLENE GROUP; R REPRESENTS A HYDROGEN ATOM OR A C1- 3 ALKYL GROUP; R1 AND R2 EACH REPRESENT A HYDROGEN ATOM OR A C1- 3 ALKYL GROUP, WITH THE PROVISO THAT THE SUM TOTAL OF CARBON ATOMS IN R1 AND R2 IS NOT MORE THAN 4; AND HET REPRESENTS BENZOHETEROARYL OR A MONOCYCLIC HETEROARYL GROUP WHEREIN THE HETEROARYL GROUP IS 5 OR 6 MEMBERED AND CONTAINS1, 2, OR 3 HETERO ATOMS ONE OF WHICH IS A NITROGEN ATOM AND THE OTHER (S) IS (ARE) NITROGEN, OXYGEN OR SULPHUR ATOM (S), AND THE GROUP HET MAY OPTIONALLY BE SUBSTITUTED BY ONE OR TWO GROUPS SELECTED FROM C1-4 ALKYL, C1- 4 ALKOXY, HYDROXY, HALOGEN, -NR3 R4 AND - COR8; WHERE R3 AND R4 EACH REPRESENT A HYDROGEN ATOM OR A C1- 4 ALKYL GROUP OR -NR3R4 FORMS A SATURATED HETEROCYCLIC AMINO GROUP WHICH HAS 5- 7 RING MEMBERS AND OPTIONALLY CONTAINS IN THE RING ONE OR MORE ATOMS SELECTED FROM -0- OR -S-OR A GROUP -NH- OR -N (CH3);- AND R8 REPRESENTS HYDROXY, C1- 4 ALKOXY OR - NR3R4 WITH THE PROVISO THAT(i) WHEN HET REPRESENTS A PYRIDYL GROUP SUBSTITUTED BY THE GROUP -NR3R4 OR -COR8 AND Q IS A CHLORINE ATOM, OR (ii) WHEN HET REPRESENTS A PYRIDYL GROUP OPTIONALLY SUBSTITUTED BY ONE OR TWO GROUPS SELECTED FROM HALOGEN, HYDROXY, C1- 3 ALKYL AND C1- 3 ALKOXY, AND Y REPRESENTS A BOND OR A C1- 4 ALKYLENE, C2- 4 ALKENYLENE OR C2- 4 ALKYNYLENE CHAIN, THEN IN BOTH CASES, R REPRESENTS A C1- 3 ALKYL GROUP AND/OR AT LEAST ONE OF THE CHAINS -XCH2- AND -CH2Y- IS SUBSTITUTED BY ONE OR TWO C1- 3 ALKYL GROUPS. THE COMPOUNDS HAVE A STIMULANT ACTION AT 2- ADRENORECEPTORS AND MAY BE USED IN THE TREATMENT OF DISEASES ASSOCIATED WITH REVERSIBLE AIRWAYS OBSTRUCTION SUCH AS ASTHMA AND CHRONIC BRONCHITIS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI89000167A MY103817A (en) | 1989-02-10 | 1989-02-10 | Chloroaniline derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI89000167A MY103817A (en) | 1989-02-10 | 1989-02-10 | Chloroaniline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY103817A true MY103817A (en) | 1993-09-30 |
Family
ID=79604041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI89000167A MY103817A (en) | 1989-02-10 | 1989-02-10 | Chloroaniline derivatives |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY103817A (en) |
-
1989
- 1989-02-10 MY MYPI89000167A patent/MY103817A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0015193A (en) | Compound, pharmaceutical composition, use of a compound, and, method for treating a condition associated with reduced nicotine transmission, for treatment or prophylaxis of psychotic disorders or disorders of intellectual impairment and for treatment or prophylaxis of human diseases or conditions | |
| HUP9802822A2 (en) | Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients | |
| DE60140456D1 (en) | AZA HETEROCYCLIC DERIVATIVES AND ITS THERAPEUTIC USE | |
| ATE294577T1 (en) | USE OF SULFAMATE DERIVATIVES TO TREAT IMPULSIVE DISORDERS | |
| ATE139233T1 (en) | ANNELATED THIOPHENE DERIVATIVES, THEIR PREPARATION AND USE | |
| EP0303465A3 (en) | Phenethanolamine derivatives | |
| DE69811329D1 (en) | Imidazolidin-4-one derivatives can be used as anti-cancer agents | |
| NZ332658A (en) | Halo-substituted bis-indolylmaleimide derivatives and pharmaceutical compositions | |
| NZ213840A (en) | Dichloroaniline derivatives and pharmaceuticals | |
| ATE39350T1 (en) | AMINOPHENOL DERIVATIVES. | |
| IL136911A0 (en) | Heterocyclic topoisomerase poisons | |
| ATE174593T1 (en) | NEW BISOXADIAZOLIDINE DERIVATIVES | |
| BG105123A (en) | Tetrahydroquinaline derivatives as glycine antagonists | |
| ES8404311A1 (en) | Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application. | |
| NO960441L (en) | Benzopyrans and pharmaceutical compounds containing them | |
| DE69226931D1 (en) | Guanidinothiazole derivatives and their use as H2-receptor antagonists | |
| ES2002036A6 (en) | Dichloroaniline derivatives | |
| AU2059688A (en) | Chloroaniline derivatives | |
| ES2192671T3 (en) | TRICYCLE COMPOUNDS THAT HAVE ACTIVITY AS INHIBITORS OF RAS-FPT. | |
| DE69403896D1 (en) | 4-AMINO-2- (HETERO) ARYL-BUTANAMIDES CAN BE USED AS 5-HT1A ANTAGONISTS | |
| MY101756A (en) | Dichloroaniline derivatives | |
| KR870000011A (en) | Herbicidal compositions based on dichloroquinoline derivatives |